GEN presents data compiled by Morningstar's Morningstar Direct asset management platform for StockWatch of the top five ...

New research from scientists at the University of Washington (UW) School of Medicine and Duke University describes how cellular RNA helps regulate antiviral signaling as part of the immune ...

The seasonal influenza vaccine contains strains of viruses from distinct virus subtypes, but most people who are vaccinated will mount a strong immune response to one strain, leaving them ...

Developing motor neurons from stem cells taken directly from amyotrophic lateral sclerosis (ALS) patients offers new hope for better understanding and treatment of the fatal neurodegenerative ...

The field of cell and gene therapy has seen a wave of exciting advances in the past 12 months. Following the landmark approval of the first CRISPR-based cell therapy in late 2023, investigators ...

Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of NG-350A, a new gene therapy based on its proprietary tumor ...

Researchers at NYU College of Dentistry and NYU Grossman School of Medicine reported the findings of a study in mice that outlines new discoveries about the roles of calcium signaling, regulatory ...

Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business unit, established a U.S ...

Craniopharyngioma, a benign yet highly invasive tumor occurring along the hypothalamus-pituitary axis, presents a unique clinical challenge. Although nonmalignant, its proximity to critical brain ...

The process by which fungi synthesize some of their most potent compounds has remained unclear for many years. This is especially true of cyclopentachromone, a key building block in fungal ...

In the beginning, Genesis Therapeutics spun out from the Stanford University lab of Vijay Pande, PhD, where Evan Feinberg, PhD, then a graduate student, co-invented and co-authored key peer ...

Recently, Charles River Laboratories—a provider of products and services for drug research and development—presented a webinar about starting material for manufacturing cell therapies.